Multiple sclerosis and COVID-19: Assessing risk perception, patient behaviors and access to disease-modifying therapies. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.msard.2022.104121
PubMed Identifier: 36088727
Publication URI: http://europepmc.org/abstract/MED/36088727
Type: Journal Article/Review
Volume: 68
Parent Publication: Multiple sclerosis and related disorders
ISSN: 2211-0348